Eisai
4523.T
#2341
Rank
C$10.96 B
Marketcap
C$38.87
Share price
-2.37%
Change (1 day)
-2.62%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.19. an increase over its 2024 EPS that were of C$1.34.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025C$1.5011.85%
2024C$1.34-32.63%
2023C$1.995.52%
2022C$1.88-74.01%
2021C$7.24-66.58%
2020C$21.6798.24%
2019C$10.9317.01%
2018C$9.3437.78%
2017C$6.78-27.62%
2016C$9.3735.33%
2015C$6.92-2.82%
2014C$7.12-27.66%
2013C$9.85-27.49%
2012C$13.58-12.67%
2011C$15.5588.08%
2010C$8.27-11.06%
2009C$9.30-390.15%
2008C-$3.20-127.78%
2007C$11.5411.78%
2006C$10.324.38%
2005C$9.897.4%
2004C$9.2143.03%
2003C$6.4425.09%
2002C$5.1552.67%
2001C$3.3769.76%
2000C$1.99